Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chinook Therapeutics (KDNY)
NASDAQ:KDNY
Chinook Therapeutics (KDNY) Ownership - Who Owns Chinook Therapeutics?
459 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 19, 2023 | Jerel Davis Director | Sold | $6138016 |
| Dec 15, 2022 | Eric Dobmeier President & Ceo,director | Bought | $10500 |
| Sep 06, 2022 | Thomas Dolca Director | Bought | $212194 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2023 | Sold | $831154 | |
| Jun 30, 2023 | Sold | $17486028 | |
| Jun 30, 2023 | Sold | $33687926 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,475 | Institution | <0.01% | 29,913 |
FAQ
Who Owns Chinook Therapeutics (KDNY)?
Currently, no data Available
What percentage of Chinook Therapeutics (KDNY) stock is held by institutional investors?
Currently, no data Available
What percentage of Chinook Therapeutics (KDNY) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Chinook Therapeutics (KDNY)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.